Losay V, Damania B
Viruses. 2025; 17(2).
PMID: 40006930
PMC: 11860327.
DOI: 10.3390/v17020177.
Niu D, Ma Y, Ren P, Chang S, Li C, Jiang Y
PLoS Pathog. 2024; 20(9):e1012535.
PMID: 39255317
PMC: 11421797.
DOI: 10.1371/journal.ppat.1012535.
Lurain K, Ramaswami R, Krug L, Whitby D, Ziegelbauer J, Wang H
Clin Microbiol Rev. 2024; 37(3):e0002223.
PMID: 38899877
PMC: 11391709.
DOI: 10.1128/cmr.00022-23.
Patel R, Lurain K, Yarchoan R, Ramaswami R
Expert Rev Anti Infect Ther. 2023; 21(9):929-941.
PMID: 37578202
PMC: 10529793.
DOI: 10.1080/14787210.2023.2247161.
Lurain K, Ramaswami R, Yarchoan R
Semin Hematol. 2023; 59(4):183-191.
PMID: 36805886
PMC: 9971650.
DOI: 10.1053/j.seminhematol.2022.11.002.
Targeting Kaposi's sarcoma associated herpesvirus encoded protease (ORF17) by a lysophosphatidic acid molecule for treating KSHV associated diseases.
Misbahuddin M Rafeeq , Habib A, Nahhas A, Binothman N, Aljadani M, Almulhim J
Front Cell Dev Biol. 2023; 11:1060156.
PMID: 36733461
PMC: 9888664.
DOI: 10.3389/fcell.2023.1060156.
Kaposi Sarcoma, a Trifecta of Pathogenic Mechanisms.
Rusu-Zota G, Manole O, Gales C, Porumb-Andrese E, Obada O, Mocanu C
Diagnostics (Basel). 2022; 12(5).
PMID: 35626397
PMC: 9140574.
DOI: 10.3390/diagnostics12051242.
The gammaherpesvirus 68 viral cyclin facilitates expression of LANA.
Niemeyer B, Sanford B, Gibson J, Berger J, Oko L, Medina E
PLoS Pathog. 2021; 17(11):e1010019.
PMID: 34780571
PMC: 8629379.
DOI: 10.1371/journal.ppat.1010019.
KSHV/HHV8-mediated hematologic diseases.
Cesarman E, Chadburn A, Rubinstein P
Blood. 2021; 139(7):1013-1025.
PMID: 34479367
PMC: 8854683.
DOI: 10.1182/blood.2020005470.
An Update of the Virion Proteome of Kaposi Sarcoma-Associated Herpesvirus.
Nabiee R, Syed B, Ramirez Castano J, Lalani R, Totonchy J
Viruses. 2020; 12(12).
PMID: 33276600
PMC: 7761624.
DOI: 10.3390/v12121382.
Epigenetic control in Kaposi sarcoma-associated herpesvirus infection and associated disease.
Frohlich J, Grundhoff A
Semin Immunopathol. 2020; 42(2):143-157.
PMID: 32219477
PMC: 7174275.
DOI: 10.1007/s00281-020-00787-z.
Herpesviral Latency-Common Themes.
Weidner-Glunde M, Kruminis-Kaszkiel E, Savanagouder M
Pathogens. 2020; 9(2).
PMID: 32075270
PMC: 7167855.
DOI: 10.3390/pathogens9020125.
Models of Oncoproteins Encoded by Kaposi's Sarcoma-Associated Herpesvirus.
Bravo Cruz A, Damania B
J Virol. 2019; 93(11).
PMID: 30867309
PMC: 6532075.
DOI: 10.1128/JVI.01053-18.
Breaking Bad: How Viruses Subvert the Cell Cycle.
Fan Y, Sanyal S, Bruzzone R
Front Cell Infect Microbiol. 2018; 8:396.
PMID: 30510918
PMC: 6252338.
DOI: 10.3389/fcimb.2018.00396.
Host Tumor Suppressor p18 Functions as a Potent Cell-Intrinsic Inhibitor of Murine Gammaherpesvirus 68 Reactivation and Pathogenesis.
Niemeyer B, Oko L, Medina E, Oldenburg D, White D, Cool C
J Virol. 2018; 92(6).
PMID: 29298882
PMC: 5827403.
DOI: 10.1128/JVI.01604-17.
The Kaposi's sarcoma-associated herpesvirus (KSHV) non-structural membrane protein K15 is required for viral lytic replication and may represent a therapeutic target.
Abere B, Mamo T, Hartmann S, Samarina N, Hage E, Ruckert J
PLoS Pathog. 2017; 13(9):e1006639.
PMID: 28938025
PMC: 5627962.
DOI: 10.1371/journal.ppat.1006639.
Kaposi sarcoma herpesvirus pathogenesis.
Mariggio G, Koch S, Schulz T
Philos Trans R Soc Lond B Biol Sci. 2017; 372(1732).
PMID: 28893942
PMC: 5597742.
DOI: 10.1098/rstb.2016.0275.
Nuclease escape elements protect messenger RNA against cleavage by multiple viral endonucleases.
Muller M, Glaunsinger B
PLoS Pathog. 2017; 13(8):e1006593.
PMID: 28841715
PMC: 5589255.
DOI: 10.1371/journal.ppat.1006593.
microRNA dependent and independent deregulation of long non-coding RNAs by an oncogenic herpesvirus.
Sethuraman S, Gay L, Jain V, Haecker I, Renne R
PLoS Pathog. 2017; 13(7):e1006508.
PMID: 28715488
PMC: 5531683.
DOI: 10.1371/journal.ppat.1006508.
Primary lymphocyte infection models for KSHV and its putative tumorigenesis mechanisms in B cell lymphomas.
Kang S, Myoung J
J Microbiol. 2017; 55(5):319-329.
PMID: 28455586
DOI: 10.1007/s12275-017-7075-2.
